Product name:
(1R,3R)-METHYL-1,2,3,4-TETRAHYDRO-2-CHLOROACETYL-1-(3,4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE
Single impurity: ≤1.0%
HPLC purity: ≥98%
Cas: 171489-59-1
MF: C22H19ClN2O5
Molecular Weight: 426.85
*The following content is generated by AI and is for reference only.
Tadalafil intermediate is a critical chemical building block used in the pharmaceutical synthesis of Tadalafil, the active ingredient in popular medications for treating erectile dysfunction and benign prostatic hyperplasia. While specific intermediates vary depending on the synthetic route employed by manufacturers, they generally refer to key precursors that undergo further chemical transformation to yield the final drug substance. Commonly associated with the core structure of the molecule, these intermediates often possess complex heterocyclic frameworks essential for the biological activity of the parent compound.
The molecular formula of the most prominent Tadalafil intermediate typically aligns with the structural backbone required before the final cyclization or functional group modification steps. Although exact formulas depend on the specific stage of synthesis (such as the 2-oxo-tetrahydroquinoline derivative), the CAS number for the generic intermediate category is not singular; however, specific high-purity precursors like 5-methoxy-2-oxo-1,2-dihydroquinoline derivatives are frequently cited in production processes. For precise identification, users must consult specific batch certificates or regulatory databases corresponding to the exact synthetic pathway. These intermediates serve as the foundational architecture upon which the pharmacologically active molecule is constructed through rigorous purification and reaction sequences.
In terms of application, Tadalafil intermediates are exclusively utilized within controlled pharmaceutical manufacturing environments. They are indispensable for producing high-quality Generic Tadalafil intended for global markets. The purity of these intermediates directly influences the efficacy and safety profile of the final medication, making strict quality control measures mandatory during their production. Manufacturers adhere to Good Manufacturing Practices (GMP) to ensure that these compounds meet international regulatory standards set by agencies such as the FDA and EMA. Beyond clinical use, research institutions may utilize these intermediates for developing novel analogs or studying structure-activity relationships to enhance therapeutic outcomes. As the demand for effective treatments for sexual health conditions continues to rise, the supply chain for these specialized chemical intermediates remains a vital component of the global pharmaceutical industry, ensuring consistent availability of life-improving therapies.